|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2011-5-12
|
|
pubmed:abstractText |
To investigate the physicochemical stability, pharmacokinetics (PK), and biodistribution of paclitaxel (PTX) from paclitaxel solid dispersion (PSD) prepared by supercritical antisolvent (SAS) process.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1520-5762
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
628-37
|
|
pubmed:meshHeading |
pubmed-meshheading:21401339-Animals,
pubmed-meshheading:21401339-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:21401339-Area Under Curve,
pubmed-meshheading:21401339-Crystallization,
pubmed-meshheading:21401339-Dose-Response Relationship, Drug,
pubmed-meshheading:21401339-Drug Stability,
pubmed-meshheading:21401339-Drug Storage,
pubmed-meshheading:21401339-Male,
pubmed-meshheading:21401339-Paclitaxel,
pubmed-meshheading:21401339-Rats,
pubmed-meshheading:21401339-Rats, Sprague-Dawley,
pubmed-meshheading:21401339-Temperature,
pubmed-meshheading:21401339-Time Factors,
pubmed-meshheading:21401339-Tissue Distribution
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process.
|
|
pubmed:affiliation |
Pharm. R&D Institute, Hanmi Pharm. Co., Ltd., Hwasung, Gyeonggi 445-913, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
